Infiltration of the brain by pathogens causes Alzheimer’s disease
Introduction
The early events in the development of Alzheimer’s disease (AD) and its pathological features—amyloid plaques and neurofibrillary tangles (NFT)—remain unclear. Currently, about 20 million people worldwide suffer from AD, and the numbers are increasing with the rise in numbers of those reaching old age. Thus, the need for effective treatments for, and (hopefully) prevention of, AD is becoming ever more urgent.
The possibility of an infectious aetiology of several chronic diseases, including AD, has long been debated. Koch’s postulates, which can in some cases provide absolute proof that a particular microorganism causes a particular disease, have been invaluable in the prevention and treatment of many diseases as well as in advancing microbiology. However, the postulates do not hold for chronic diseases of possible microbial aetiology, particularly those occurring late in life, or for those of possible viral aetiology, or for those that are multifactorial in origin. In diseases of relatively old age, a microbe acting earlier in life might operate by a “hit-and-run” mechanism, or could eventually be present only at an extremely low level, so that searches for the organism might reveal nothing even if it had initiated damage. In viral diseases, the postulates requiring isolation and growth in pure culture cannot be met as viruses reproduce only within living cells. In multifactorial diseases, a causative organism would not be present in those whose disease is due to other factors. However, absence of evidence is not evidence of absence: in several cases when, eventually, overwhelming experimental evidence was obtained, the pathogen concept had to be accepted even though it had met with great opposition initially; two examples are the involvement of viruses in certain types of cancer, and of a bacterium in stomach ulcers.
The detailed research that has been made seeking and detecting two pathogens in brain, herpes simplex virus type 1 (HSV1), and Chlamydia pneumoniae, is described here. The “hit-and-run” theme is not pursued because no such studies have been made in respect to AD and indeed it is obviously very difficult to devise appropriate experiments.
Section snippets
Herpes simplex virus type 1 and AD
A possible viral involvement in the etiopathogenesis of AD was first suggested in 1977 [17]. Later, in 1982, HSV1 was proposed as a likely candidate virus [3] because in herpes simplex encephalitis (HSE), a very rare but extremely serious acute infection of the central nervous system (CNS), the earliest and most severely affected regions are the same as those showing the earliest and most severe pathological changes in AD. Although HSE is a very different disease from AD, it leads to certain
Other herpesviruses and AD
A role for other herpesviruses in AD has been investigated also. Human herpesvirus 6 (HHV6) was found in brain of a much higher proportion of sufferers than aged normals suggesting that this virus might be a risk [36]; however, an equally valid conclusion is that AD brains are more susceptible to the virus. Nevertheless, animal models have shown that HHV6 enhances the damage caused by HSV1, suggesting that HHV6 might enhance the damage caused by HSV1 in AD brain. Other viruses (herpes simplex
Epidemiological studies
Three recent studies of a very different type support a viral role in AD, even if indirectly: (a) AD patients showed a decline in cognitive function for at least two months after a systemic infection, associated probably with microglial cell activation caused by entry of cytokines into the brain [23]; (b) cognitive impairment in elderly cardiovascular patients was associated with viral pathogen burden (HSV1 alone and with HSV2 and cytomegalovirus) [56]; and (c) vaccination against various
Chlamydia pneumoniae and AD
Another organism that has been linked to AD is C. pneumoniae. In this case, the bacterial DNA has been found (in some studies) to be present in brain of a very high proportion of AD patients but in only very few age-matched normals, indicating a greater susceptibility to entry and infection of brain by the bacterium (and possibly also to damage by the latter) in AD patients rather than, as with HSV1, a greater susceptibility to damage of the nervous system.
Other bacteria and AD
In the brains of neuropathologically confirmed cases of AD, bacteria other than C. pneumoniae have been found [44]. In particular, spirochetes were detected in the blood and cerebrospinal fluid from AD patients. Furthermore, these organisms were isolated and cultured from AD patients [44]. Ultrastructural analysis indicated that taxonomically these organisms were in the order of Spirochaetaes. Intriguingly, the tick-borne pathogen Borrelia burgdorferi is the major human spirochetal infection in
Epilogue
There are defined technical difficulties in consistently determining infection associated with chronic disease throughout the body. A relatively primitive understanding of issues of latency of infection, dissemination of infection throughout the body, and strain heterogeneity of a variety of unique microorganisms requires tempered conclusions at this time. Nonetheless, a microbial involvement in AD points to the use of well-established anti-microbial agents for the treatment of the disease. In
Acknowledgements
We thank the Adolph and Rose Levis Foundation for supporting the ongoing development of the C. pneumoniae animal models, and Dr. M. Ball for helpful comments (supported in part from NIH Grant # AG 08017).
References (63)
- et al.
HSV-1 in brain and risk of Alzheimer’s disease
Lancet
(1998)See also, Corder E, et al. Apolipoprotein E and herpes simplex virus in Alzheimer’s disease. Lancet... - et al.
Abnormal processing of amyloid precursor protein after acute infection of human neuroblastoma cells with herpes simplex virus type 1s
Neurobiol. Aging
(2002) - et al.
Prevalence of Alzheimer plaques in AIDS
J. Neurol. Neurosurg. Psychiatry
(1998) - et al.
A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR
J. Infect. Dis.
(1990) - et al.
Herpesviruses in brains in Alzheimer’s and Parkinson’s diseases
Ann. Neurol.
(2003) - et al.
Herpes simplex virus type 1 and Alzheimer’s disease
Ann. Neurol.
(2004) - Itzhaki RF, Maitland NJ, Wilcock GK, Yates CM, Jamieson GA. Detection by polymerase chain reaction of herpes simplex...
- et al.
Neurotropic viruses and Alzheimer’s disease: a search for varicella zoster virus DNA by the polymerase chain reaction
J. Neurol. Neurosurg. Psychiatry
(1997) - et al.
Herpesviruses in brain and Alzheimer’s disease
J. Pathol.
(2002) - et al.
Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains in BALB/c mice
Neurobiol. Aging
(2004)
Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells
J. Neurosci. Res.
Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer’s disease
Neurology
Presence of herpes simplex DNA in surgical tissue from human epileptic seizure foci detected by polymerase chain reaction: preliminary study
Arch. Neurol.
Initial interaction of herpes simplex virus with cells is binding to heparan sulfate
J. Virol.
Chlamydia pneumoniae infection in human monocytes [published erratum appears in Infect Immun 1999;67:6716]
Infect. Immun.
Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain
Med. Microbiol. Immunol. (Berl.)
Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved?
Can. J. Neurol. Sci.
Unexplained sudden amnesia, postencephalitic Parkinson disease, subacute sclerosing panencephalitis, and Alzheimer disease: does viral synergy produce neurofibrillary tangles?
Arch. Neurol.
Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction
Ann. Neurol.
Distribution of herpes simplex virus type 1 DNA in selected areas of normal and Alzheimer’s disease brains: a PCR study
Neurodegeneration
High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors
J. Infect. Dis.
Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular endothelial cells result in increased expression of CC chemokines
J. Neurovirol.
ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1
Neuroreport
HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy
Nat. Med.
Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer’s A beta peptide
Biochemistry
Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer’s disease entorhinal cortex
Neurosci. Lett.
Do infectious agents play a role in dementia?
Trends Microbiol.
Unconventional viruses and the origin and disappearance of kuru
Science
Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer’s disease patients
J. Clin. Microbiol.
Detection of herpes simplex virus (types 1 and 2) and human herpesvirus 6 DNA in human brain tissue by polymerase chain reaction
Clin. Diagn. Virol.
Cited by (168)
Alzheimer’s disease-associated β-amyloid does not protect against herpes simplex virus 1 infection in the mouse brain
2021, Journal of Biological ChemistryThe association between PM<inf>2.5</inf> exposure and neurological disorders
2021, Air Pollution, Climate, and Health: An Integrated Perspective on Their InteractionsThe association between PM <inf>2.5</inf> exposure and neurological disorders: A systematic review and meta-analysis
2019, Science of the Total EnvironmentA review on nonviral, nonbacterial infectious agents toxicity involved in neurodegenerative diseases
2023, Neurodegenerative Disease ManagementThe Involvement of Melatonin and Tasimelteon against Alzheimer’s Disease
2023, Current Drug Safety